Dashboard
Manage Tickers

IRWDIRONWOOD PHARMACEUTICALS INC

Nasdaq ironwoodpharma.com


$ 8.12 $ -0.18 (-2.17 %)    

Friday, 03-May-2024 15:59:56 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 435.98 $ 8.58 (2.01 %)
DIA $ 386.87 $ 4.54 (1.19 %)
SPY $ 511.25 $ 6.26 (1.24 %)
TLT $ 89.88 $ 0.90 (1.01 %)
GLD $ 212.97 $ -0.17 (-0.08 %)
$ 8.12
$ 8.44
$ 0.00 x 0
$ 8.13 x 100
$ 8.11 - $ 8.44
$ 7.53 - $ 15.70
1,863,557
na
1.26B
$ 0.45
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 02-16-2024 12-31-2023 10-K
2 11-09-2023 09-30-2023 10-Q
3 08-09-2023 06-30-2023 10-Q
4 05-04-2023 03-31-2023 10-Q
5 02-16-2023 12-31-2022 10-K
6 11-03-2022 09-30-2022 10-Q
7 08-04-2022 06-30-2022 10-Q
8 05-05-2022 03-31-2022 10-Q
9 02-17-2022 12-31-2021 10-K
10 11-04-2021 09-30-2021 10-Q
11 08-05-2021 06-30-2021 10-Q
12 05-06-2021 03-31-2021 10-Q
13 02-17-2021 12-31-2020 10-K
14 11-05-2020 09-30-2020 10-Q
15 08-06-2020 06-30-2020 10-Q
16 05-06-2020 03-31-2020 10-Q
17 02-13-2020 12-31-2019 10-K
18 10-31-2019 09-30-2019 10-Q
19 07-30-2019 06-30-2019 10-Q
20 05-02-2019 03-31-2019 10-Q
21 02-25-2019 12-31-2018 10-K
22 11-06-2018 09-30-2018 10-Q
23 08-06-2018 06-30-2018 10-Q
24 05-04-2018 03-31-2018 10-Q
25 02-22-2018 12-31-2017 10-K
26 11-02-2017 09-30-2017 10-Q
27 08-03-2017 06-30-2017 10-Q
28 05-08-2017 03-31-2017 10-Q
29 02-22-2017 12-31-2016 10-K
30 11-07-2016 09-30-2016 10-Q
31 08-08-2016 06-30-2016 10-Q
32 05-10-2016 03-31-2016 10-Q
33 02-19-2016 12-31-2015 10-K
34 11-05-2015 09-30-2015 10-Q
35 08-07-2015 06-30-2015 10-Q
36 05-06-2015 03-31-2015 10-Q
37 02-18-2015 12-31-2014 10-K
38 11-05-2014 09-30-2014 10-Q
39 08-05-2014 06-30-2014 10-Q
40 04-29-2014 03-31-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

ironwood-pharmaceuticals-announces-results-from-phase-2-exploratory-stargaze-trial-of-apraglutide-for-steroid-refractory-gastrointestinal-acute-graft-versus-host-disease
Ironwood Pharmaceuticals Announces Results...
03/28/2024 11:33:10

First prospective trial of a glucagon-like peptide (GLP-2) analog in SR GI aGVHD. Results up to Day 91 show that apraglutide...

top-3-health-care-stocks-that-could-lead-to-your-biggest-gains-in-march
Top 3 Health Care Stocks That Could Lead T...
03/07/2024 12:18:46

The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.

wells-fargo-maintains-overweight-on-ironwood-pharmaceuticals-lowers-price-target-to-14
Wells Fargo Maintains Overweight on Ironwo...
03/01/2024 18:00:24

Wells Fargo analyst Mohit Bansal maintains Ironwood Pharmaceuticals (NASDAQ:IRWD) with a Overweight and lowers the price tar...

why-butterfly-network-shares-are-trading-lower-by-22-here-are-other-stocks-moving-in-thursdays-mid-day-session
Why Butterfly Network Shares Are Trading L...
02/29/2024 19:00:01

Shares of Butterfly Network, Inc. (NASDAQ: BFLY) fell sharply during Thursday’s session after the company reported mixed four...

12-health-care-stocks-moving-in-thursdays-intraday-session
12 Health Care Stocks Moving In Thursday's...
02/29/2024 17:32:04

why-is-gastrointestinal-healthcare-focused-ironwood-pharmaceuticals-stock-sinking-on-thursday
Why Is Gastrointestinal Healthcare Focused...
02/29/2024 16:34:52

Ironwood Pharmaceuticals' SBS-IF treatment Apraglutide's Phase 3 trial met primary endpoints, reducing PS dependency by...

nasdaq-gains-100-points-following-pce-data
Nasdaq Gains 100 Points Following PCE Data
02/29/2024 15:40:00

U.S. stocks traded mostly higher this morning, with the Nasdaq Composite gaining around 100 points on Thursday. Following the ...

tech-stocks-set-to-rise-thursday-as-january-inflation-data-fails-to-scare-markets-small-caps-surge
Tech Stocks Set To Rise Thursday As Januar...
02/29/2024 14:20:35

Tech stocks drive pre-market surge, Fed inflation data fails to disrupt rate cut expectations. Futures up for Nasdaq, S&P 5...

12-health-care-stocks-moving-in-thursdays-pre-market-session
12 Health Care Stocks Moving In Thursday's...
02/29/2024 13:07:01

ironwood-pharmaceuticals-announced-topline-results-from-its-pivotal-phase-3-stars-trial-of-once-weekly-subcutaneous-apraglutide-in-reducing-parenteral-support-dependency-in-adult-patients-with-short-bowel-syndrome-with-intestinal-failure
Ironwood Pharmaceuticals Announced Topline...
02/29/2024 11:17:06

Apraglutide met the primary endpoint of relative change from baseline in actual weekly parenteral support (PS) volume at week 2...

top-4-health-care-stocks-you-may-want-to-dump-in-february
Top 4 Health Care Stocks You May Want To D...
02/15/2024 13:15:49

As of Feb. 15, 2024, four stocks in the health care sector could be flashing a real warning to investors who value momentum as ...

ironwood-pharmaceuticals-expects-fy24-sales-between-435m-455m-vs-46282m-estimate-sees-fy24-adjusted-ebitda-above-150m
Ironwood Pharmaceuticals Expects FY24 Sale...
02/15/2024 12:13:24

ironwood-pharmaceuticals-q4-sales-11755m-beat-11748m-estimate-generated-358m-in-cash-from-operations-in-q4
Ironwood Pharmaceuticals Q4 Sales $117.55M...
02/15/2024 12:10:06

Ironwood Pharmaceuticals (NASDAQ:IRWD) reported quarterly sales of $117.55 million which beat the analyst consensus estimate of...

earnings-scheduled-for-february-15-2024
Earnings Scheduled For February 15, 2024
02/15/2024 10:17:01

Companies Reporting Before The Bell • Cognex (NASDAQ:CGNX) is estimated to report quarterly earnings at $0.10 per share on rev...

a-preview-of-ironwood-pharmaceuticalss-earnings
A Preview Of Ironwood Pharmaceuticals's Ea...
02/14/2024 18:02:09

craig-hallum-initiates-coverage-on-ironwood-pharmaceuticals-with-buy-rating-announces-price-target-of-21
Craig-Hallum Initiates Coverage On Ironwoo...
01/17/2024 15:07:04

Craig-Hallum analyst Chase Knickerbocker initiates coverage on Ironwood Pharmaceuticals (NASDAQ:IRWD) with a Buy rating and ...

ironwood-announces-publication-in-the-lancet-gastroenterology--hepatology-of-new-linaclotide-phase-iii-data-in-children-and-adolescents-aged-6-17-years-with-functional-constipation
Ironwood Announces Publication In The Lanc...
01/09/2024 03:59:20

– Newly published data highlights additional efficacy endpoints from trial –– Linaclotide is the first and only FDA-approved pr...

ironwood-pharmaceuticals-sees-fy24-linzess-us-net-sales-growth-of-low-single-digits--with-revenue-guidance-of-435m-455m-versus-consensus-of-46580m
Ironwood Pharmaceuticals Sees FY24 Linzess...
01/08/2024 11:07:49

For LINZESS, the company sees High-single digit prescription demand growth offset by mid to high-single digit price erosion pri...

ironwood-pharmaceuticals-maintains-fy23-linzess-us-net-sales-growth-of-6-8-with-total-revenue-guidance-of-435m-450m-versus-consensus-of-44402m
Ironwood Pharmaceuticals Maintains FY23 Li...
01/08/2024 11:05:22

Ironwood Pharmaceuticals Expects FY23 Addjusted EBITDA Of ~$(900)M, Reflects ~$1.1 billion one-time charge from acquisition of ...

wells-fargo-initiates-coverage-on-ironwood-pharmaceuticals-with-overweight-rating-announces-price-target-of-20
Wells Fargo Initiates Coverage On Ironwood...
12/14/2023 12:39:43

Wells Fargo analyst Mohit Bansal initiates coverage on Ironwood Pharmaceuticals (NASDAQ:IRWD) with a Overweight rating and a...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION